To explore the possible mechanism by which CV1 promotes the anti-tumor effect of CDH17-CAR-NK92 cells, we performed flow cytometry analysis for macrophages in the tumor microenvironment after treatment (Fig. 6F and G, Supporting Information Fig. S16). Here, CDH17 is linked to neoplasm.